Clinical Trials Directory

Trials / Completed

CompletedNCT05993871

Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of work is to study the clinical, electrodiagnostic and neurosonographic characteristics of diabetic patients with small fiber neuropathy in the Egyptian population, and to evaluate both the diagnostic and the prognostic impact of the studied factors on the neuropathy severity and quality of life.

Detailed description

This case-control observational study is aiming to evaluate patients with diabetic small fiber neuropathy in the Egyptian. Diabetic small fiber neuropathy was defined as both of the following: A. Typical clinical symptoms of SFN such as burning or sharp pain in toes and feet, and on clinical examination: loss of small fiber modalities (pinprick and temperature), hyperalgesia, allodynia, and/or autonomic signs. B. Reduced intraepidermal nerve fiber density (IENFD) in distal leg skin punch biopsy. The study includes 3 groups: Group I: Patients with diabetic small fiber neuropathy Group II (Control Group): Patients with diabetic mixed small and large fiber neuropathy Group III (Control Group): Subjects without peripheral neuropathy Clinical evaluation includes: Neuropathic Pain 4 (DN4) questionnaire, 11-point Numeric Pain Scale (NPS), Utah Early Neuropathy Scale (UENS), Toronto Clinical Neuropathy Scale (TCNS), Composite Autonomic Symptom Score (COMPASS-31), an Arabic version, and several anthropometric measures; including: body weight in kilograms, height in centimeters, waist circumference measured in centimeters at the top of the iliac crest, and systolic "SBP" and diastolic "DBP" blood pressure measurement in mmHg. Electrodiagnostic evaluation includes: routine nerve conduction study, cutaneous silent period by stimulating left median nerve and right sural nerve and recording from the abductor pollicis brevis and tibialis anterior muscles, respectively, bilateral hand-to hand and foot-to-foot sympathetic skin response, and Ewing battery using R-R interval analysis, in addition to the blood pressure tests. Neurosonographic evaluation includes: bilateral vagal nerve scan at the mid-neck lateral to the thyroid cartilage, left median and right ulnar nerves scan at the mid-forearm, left tibial nerve at the distal ankle 2 to 4 fingerbreadths proximal to the medial malleolus, and right sural nerve 2 to 4 fingerbreadths proximal to the lateral malleolus. Nerves are evaluated for transverse cross-sectional area (CSA). Severity and outcome measures are assessed using: NPS, TCNS, COMPASS-31, and the index score of Euro Quality of Life -5 Dimensions -5 Levels (EuroQOL-5D-5L), the Arabic version.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTClinical Evaluation/QuestionnairesAnthropometric measures, somatosensory assessment (NPS, UENS, TCNS), autonomic assessment (COMPASS-31, Ewing battery), and severity and quality of life evaluation (NPS, TCNS, COMPASS-31, and EuroQOL-5D-5L index score)
DIAGNOSTIC_TESTNerve Conduction StudyRoutine Nerve Conduction Study.
DIAGNOSTIC_TESTSmall fiber electrodiagnostic testsR-R interval analysis, Cutaneous Silent Period and Sympathetic Skin Response.
DIAGNOSTIC_TESTNerve UltrasoundBilateral vagal, left median, right ulnar, left tibial and right sural nerves ultrasound.
DIAGNOSTIC_TESTSkin Biopsydistal leg 3mm punch skin biopsy

Timeline

Start date
2023-01-01
Primary completion
2023-06-30
Completion
2024-01-22
First posted
2023-08-15
Last updated
2024-04-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05993871. Inclusion in this directory is not an endorsement.